SlideShare a Scribd company logo
1 of 35
INTRO TO TEST
CHARACTERISTICS
BRIAN LOCKE, MD
PGY2 INTERNAL MEDICINE
UNIVERSITY OF UTAH
UPDATED APR 12 2018
OBJECTIVES
Be able to:
Define sensitivity and specificity
Construct a contingency table for a given test and condition
What factors influence positive predictive value and negative
predictive values?
PREVALENCE AND
INCIDENCE
Measures of how common a disease is:
Prevalence = cases per population at risk
Incidence = number of new cases per population at risk
SENSITIVITY
Among patients who have the disease, how often will the test
be positive
High Sensitivity = almost never misses someone with disease
Low sensitivity = can often be negative in someone with
disease
SPECIFICITY
Among patients who do not have the disease, how often will
the test be negative?
High specificity = test is almost always negative if the person
does not have disease
Low specificity = test can often be positive in someone who
does not have the disease
EXAMPLE 1:
D-dimer over 500 for pulmonary embolism
• Sensitivity = 99.5%
• Specificity = 41%
• Prevalence in tested outpatients = 29%
• Am J Respir Crit Care Med. 1997 Aug;156(2 Pt 1):492-6
How should we interpret a positive or negative result?.
CONTINGENCY TABLE
Possibilities of disease states and test results
Has Disease (D+) Does Not Have
Disease (D-)
Test positive (T+)
Test negative (T-)
CONTINGENCY TABLE
Possibilities of disease states and test results
Has Disease (D+) Does Not Have
Disease (D-)
Test positive (T+) True Positive False Positive
Test negative (T-) False Negative True Negative
PREVALENCE AND
INCIDENCE
Prevalence = cases per population at risk
Incidence = number of new cases per population at risk
• How does high vs low prevalence affect the contingency
table?
Has Disease (D+) Does Not Have
Disease (D-)
Test positive (T+) True Positive False Positive
Test negative (T-) False Negative True Negative
PREVALENCE AND
INCIDENCE
Prevalence = cases per population at risk
Incidence = number of new cases per population at risk
• How does high vs low prevalence affect the contingency
table? Amount in each column
Has Disease (D+) Does Not Have
Disease (D-)
Test positive (T+) True Positive False Positive
Test negative (T-) False Negative True Negative
EXAMPLE 1:
Has Disease (D+)
= 2900
Does Not Have
Disease (D-) =
7100
Test positive (T+) True Positive False Positive
Test negative (T-) False Negative True Negative
D-dimer over 500 for pulmonary embolism
• Sensitivity = 99.5%
• Specificity = 41%
• Prevalence in tested outpatients = 29%
• Am J Respir Crit Care Med. 1997 Aug;156(2 Pt 1):492-6
Let’s consider 10,000 hypothetical patients evaluated for PE:
SENSITIVITY
Among patients who have the disease, how often will the test
be positive
Has Disease (D+) Does Not Have
Disease (D-)
Test positive (T+) True Positive False Positive
Test negative (T-) False Negative True Negative
SENSITIVITY
Among patients who have the disease, how often will the test
be positive
= True Positive / (True Positive + False Negatives)
Has Disease (D+) Does Not Have
Disease (D-)
Test positive (T+) True Positive False Positive
Test negative (T-) False Negative True Negative
SPECIFICITY
Among patients who do not have the disease, how often will
the test be negative
Has Disease (D+) Does Not Have
Disease (D-)
Test positive (T+) True Positive False Positive
Test negative (T-) False Negative True Negative
SPECIFICITY
Among patients who do not have the disease, how often will
the test be negative
=True Negative / (False Positive + True Negative)
Has Disease (D+) Does Not Have
Disease (D-)
Test positive (T+) True Positive False Positive
Test negative (T-) False Negative True Negative
EXAMPLE 1:
D-dimer over 500 for pulmonary embolism
• Sensitivity = 99.5%
• Specificity = 41%
• Prevalence in tested outpatients = 29%
• Am J Respir Crit Care Med. 1997 Aug;156(2 Pt 1):492-6
Specificity = True Negative / All Negative
Sensitivity = True Positive / All Positive
Has Disease (D+)
= 2900
Does Not Have
Disease (D-) =
7100
Test positive (T+) True Positive False Positive
Test negative (T-) False Negative True Negative
EXAMPLE 1:
D-dimer over 500 for pulmonary embolism
• Sensitivity = 99.5%
• Specificity = 41%
• Prevalence in tested outpatients = 29%
• Am J Respir Crit Care Med. 1997 Aug;156(2 Pt 1):492-6
41% = True Negative / 7100
99.5% = True Positive / 2900
Has Disease (D+)
= 2900
Does Not Have
Disease (D-) =
7100
Test positive (T+) True Positive False Positive
Test negative (T-) False Negative True Negative
EXAMPLE 1:
D-dimer over 500 for pulmonary embolism
• Sensitivity = 99.5%
• Specificity = 41%
• Prevalence in tested outpatients = 29%
• Am J Respir Crit Care Med. 1997 Aug;156(2 Pt 1):492-6
True Negative = 7100 * .41 = 2911
True Positive = 2900 * .995 = 2885
Has Disease (D+)
= 2900
Does Not Have
Disease (D-) =
7100
Test positive (T+) True Positive False Positive
Test negative (T-) False Negative True Negative
EXAMPLE 1:
Has Disease
(D+)
= 2900
Does Not Have
Disease (D-) =
7100
Test positive (T+) 2885 4189 (=7100-2911)
Test negative (T-) 5 (=2900–2885) 2911
D-dimer over 500 for pulmonary embolism
• Sensitivity = 99.5%
• Specificity = 41%
• Prevalence in tested outpatients = 29%
• Am J Respir Crit Care Med. 1997 Aug;156(2 Pt 1):492-6
True Negative = 7100 * .41 = 2911
True Positive = 2900 * .995 = 2885
POSITIVE PREDICTIVE
VALUE
Among patients who test positive for the disease, how often
they have the disease
Why do we care?
Because we don’t know whether the patient has the disease
or not!
POSITIVE PREDICTIVE
VALUE
Among patients who test positive for the disease, how often
they have the disease
*requires that we know the prevalence
Unlike the sensitivity and specificity, it will vary with
prevalence. Sensitivity and specificity are characteristics of
the test.
POSITIVE PREDICTIVE
VALUE
Among patients who test positive for the disease, how often
they have the disease
= True Positives / (True Positive + False Positives)
Has Disease (D+) Does Not Have
Disease (D-)
Test positive (T+) True Positive False Positive
Test negative (T-) False Negative True Negative
NEGATIVE
PREDICTIVE VALUE
Among patients who test negative for the disease, how often
they not have the disease
= True Negative / (False Negative + True Negative)
Has Disease (D+) Does Not Have
Disease (D-)
Test positive (T+) True Positive False Positive
Test negative (T-) False Negative True Negative
EXAMPLE 1:
Has Disease (D+)
= 2900
Does Not Have
Disease (D-) =
7100
Test positive (T+) 2885 4189
Test negative (T-) 5 2911
D-dimer over 500 for pulmonary embolism
• Sensitivity = 99.5%
• Specificity = 41%
• Prevalence in tested outpatients = 29%
• Am J Respir Crit Care Med. 1997 Aug;156(2 Pt 1):492-6
• PPV = 2885 / (2885 + 4189) = 41%
• NPV = 2911 / ( 2911 + 5) = 99.8%
EXAMPLE 1B:
D-dimer over 500 for pulmonary embolism
• Sensitivity = 99.5%
• Specificity = 41%
• Prevalence in tested outpatients = 75%
• Hypothetical population with very convincing signs and symptoms
EXAMPLE 1B:
Has Disease (D+)
= 7500
Does Not Have
Disease (D-) =
2500
Test positive (T+) True Positive False Positive
Test negative (T-) False Negative True Negative
D-dimer over 500 for pulmonary embolism
• Sensitivity = 99.5%
• Specificity = 41%
• Prevalence in tested outpatients = 75%
• Hypothetical population with very convincing signs and symptoms
EXAMPLE 1B:
Has Disease (D+)
= 7500
Does Not Have
Disease (D-) =
2500
Test positive (T+) 7463 1475
Test negative (T-) 37 1025
D-dimer over 500 for pulmonary embolism
• Sensitivity = 99.5%
• Specificity = 41%
• Prevalence in tested outpatients = 75%
• Hypothetical population with very convincing signs and symptoms
EXAMPLE 1B:
D-dimer over 500 for pulmonary embolism
• Sensitivity = 99.5%
• Specificity = 41%
• Prevalence in tested outpatients = 75%
• Hypothetical population with very convincing signs and symptoms
• PPV = 7463 / (7463 + 1475) = 83%
• NPV = 1025 / ( 1025 + 37) = 96.5%
Has Disease (D+)
= 7500
Does Not Have
Disease (D-) =
2500
Test positive (T+) 7463 1475
Test negative (T-) 37 1025
EXAMPLE 2:
Testing for Rare disease
• E.g. 24h Urine Metanephrines for Pheochromocytoma
(warning: made up numbers) = prevalence of 1% (among
tested patients)
• Sensitivity = 99%
• Specificity = 99%
• PPV of a positive result?
EXAMPLE 2:
Testing for Rare disease
• E.g. 24h Urine Metanephrines for Pheochromocytoma
(warning: made up numbers) = prevalence of 1% (among
tested patients)
• Sensitivity = 99%
• Specificity = 99%
Has Disease (D+)
=100
Does Not Have
Disease (D-) =
9900
Test positive (T+) 99 99
Test negative (T-) 1 9801
EXAMPLE 2:
Testing for Rare disease
• Test positive => 99 True positive, 99 False positive!
• PPV 50%
Even good tests are not reliable in low prevalence conditions
Has Disease (D+)
=100
Does Not Have
Disease (D-) =
9900
Test positive (T+) 99 99
Test negative (T-) 1 9801
EXAMPLE 3
Lung Ca Screening w/ Low dose CT: (Br J Cancer. 2008 May
20;98(10):1602-7)
• Sensitivity 88.9, Specificity 92.6
• Prevalence: age-adjusted incidence rate of lung cancer is 62
per 100,000 men and women per year in the United States
(Clin Chest Med. 2011 Dec; 32(4): 10.1016/j.ccm.2011.09.001.)
OBJECTIVES
Be able to:
Define sensitivity and specificity
Construct a contingency table for testing for a given
condition
What factors influence positive predictive value and negative
predictive values?
OBJECTIVES
Be able to:
Define sensitivity and specificity
Sensitivity = If a patient has the disease, how often will the test be positive?
Specificity = if the patient does not have the disease, how often will the test
be negative?
Construct a contingency table for testing for a given condition
Calculate # w/ and w/o dz, use sensitivity on pts w/ and specificity on pts w/o
What factors influence positive predictive value and negative
predictive values?
PPV increases w/ higher specificity+sensitivity and prevalence
NPV increases w/ high specificity+sensitivity and lower prevalence
NEXT STEPS
How can we use these characteristics?
• Likelihood ratio
• Bayes Theorem
• Expected Value Theorem
• Questions? Brian.locke@hsc.utah.edu

More Related Content

Similar to Locke test chars

Epidemiological method to determine utility of a diagnostic test
Epidemiological method to determine utility of a diagnostic testEpidemiological method to determine utility of a diagnostic test
Epidemiological method to determine utility of a diagnostic test
Bhoj Raj Singh
 
Isabel + Mark - PE
Isabel + Mark - PEIsabel + Mark - PE
Isabel + Mark - PE
guestd97854
 
Pulmonary Embolism
Pulmonary EmbolismPulmonary Embolism
Pulmonary Embolism
guestd97854
 

Similar to Locke test chars (20)

Dr swe swe latt screening for slideshare
Dr swe swe latt screening for slideshareDr swe swe latt screening for slideshare
Dr swe swe latt screening for slideshare
 
05 diagnostic tests cwq
05 diagnostic tests cwq05 diagnostic tests cwq
05 diagnostic tests cwq
 
session three epidemiology.pptx
session three epidemiology.pptxsession three epidemiology.pptx
session three epidemiology.pptx
 
session three epidemiology.pptx
session three epidemiology.pptxsession three epidemiology.pptx
session three epidemiology.pptx
 
Screening
ScreeningScreening
Screening
 
Diagnotic and screening tests
Diagnotic and screening testsDiagnotic and screening tests
Diagnotic and screening tests
 
Biostatistics ii
Biostatistics iiBiostatistics ii
Biostatistics ii
 
Disease screening
Disease screeningDisease screening
Disease screening
 
Statistics
StatisticsStatistics
Statistics
 
screening.pptx
screening.pptxscreening.pptx
screening.pptx
 
Assessing the performance of diagnostic tests
Assessing the performance of diagnostic testsAssessing the performance of diagnostic tests
Assessing the performance of diagnostic tests
 
Ch 14 diagn test.doc
Ch 14 diagn test.docCh 14 diagn test.doc
Ch 14 diagn test.doc
 
Epidemiological method to determine utility of a diagnostic test
Epidemiological method to determine utility of a diagnostic testEpidemiological method to determine utility of a diagnostic test
Epidemiological method to determine utility of a diagnostic test
 
Ecm PE
Ecm   PEEcm   PE
Ecm PE
 
E C M PE
E C M    PEE C M    PE
E C M PE
 
Isabel + Mark - PE
Isabel + Mark - PEIsabel + Mark - PE
Isabel + Mark - PE
 
ECM PE
ECM PEECM PE
ECM PE
 
Pulmonary Embolism
Pulmonary EmbolismPulmonary Embolism
Pulmonary Embolism
 
Pulmonary embolism 2
Pulmonary embolism 2Pulmonary embolism 2
Pulmonary embolism 2
 
Probability.pdf.pdf and Statistics for R
Probability.pdf.pdf and Statistics for RProbability.pdf.pdf and Statistics for R
Probability.pdf.pdf and Statistics for R
 

More from Brian Locke

The Effect of OSA Severity and CPAP Adherence on Weight Regain After Bariatri...
The Effect of OSA Severity and CPAP Adherence on Weight Regain After Bariatri...The Effect of OSA Severity and CPAP Adherence on Weight Regain After Bariatri...
The Effect of OSA Severity and CPAP Adherence on Weight Regain After Bariatri...
Brian Locke
 

More from Brian Locke (18)

End of Code / Rapid Response Presentation
End of Code / Rapid Response PresentationEnd of Code / Rapid Response Presentation
End of Code / Rapid Response Presentation
 
Locke arrhythmia
Locke   arrhythmiaLocke   arrhythmia
Locke arrhythmia
 
Locke intro ekg
Locke   intro ekgLocke   intro ekg
Locke intro ekg
 
Locke chf greatest hits
Locke   chf greatest hitsLocke   chf greatest hits
Locke chf greatest hits
 
Ebm seminar b locke 5-16-20
Ebm seminar   b locke 5-16-20Ebm seminar   b locke 5-16-20
Ebm seminar b locke 5-16-20
 
Resident research pp final
Resident research pp finalResident research pp final
Resident research pp final
 
Locke vasopressor ppt
Locke vasopressor pptLocke vasopressor ppt
Locke vasopressor ppt
 
Virtual noon conf template
Virtual noon conf templateVirtual noon conf template
Virtual noon conf template
 
Tti top 10 on call anton locke 4-11-20
Tti  top 10 on call anton locke 4-11-20Tti  top 10 on call anton locke 4-11-20
Tti top 10 on call anton locke 4-11-20
 
Locke covid transmission 101
Locke covid transmission 101Locke covid transmission 101
Locke covid transmission 101
 
Scarce resources
Scarce resourcesScarce resources
Scarce resources
 
Covid diagnostics users guide
Covid diagnostics users guideCovid diagnostics users guide
Covid diagnostics users guide
 
Covid imaging users guide
Covid imaging users guideCovid imaging users guide
Covid imaging users guide
 
Pancpleural fistula am report locke
Pancpleural fistula am report   lockePancpleural fistula am report   locke
Pancpleural fistula am report locke
 
Pneumocystis PNa and HyperCa
Pneumocystis PNa and HyperCaPneumocystis PNa and HyperCa
Pneumocystis PNa and HyperCa
 
Brain attack poster
Brain attack posterBrain attack poster
Brain attack poster
 
The Effect of OSA Severity and CPAP Adherence on Weight Regain After Bariatri...
The Effect of OSA Severity and CPAP Adherence on Weight Regain After Bariatri...The Effect of OSA Severity and CPAP Adherence on Weight Regain After Bariatri...
The Effect of OSA Severity and CPAP Adherence on Weight Regain After Bariatri...
 
University of Utah Internal Medicine - Journal Club Curriculum
University of Utah Internal Medicine - Journal Club CurriculumUniversity of Utah Internal Medicine - Journal Club Curriculum
University of Utah Internal Medicine - Journal Club Curriculum
 

Recently uploaded

Biogenic Sulfur Gases as Biosignatures on Temperate Sub-Neptune Waterworlds
Biogenic Sulfur Gases as Biosignatures on Temperate Sub-Neptune WaterworldsBiogenic Sulfur Gases as Biosignatures on Temperate Sub-Neptune Waterworlds
Biogenic Sulfur Gases as Biosignatures on Temperate Sub-Neptune Waterworlds
Sérgio Sacani
 
Bacterial Identification and Classifications
Bacterial Identification and ClassificationsBacterial Identification and Classifications
Bacterial Identification and Classifications
Areesha Ahmad
 
biology HL practice questions IB BIOLOGY
biology HL practice questions IB BIOLOGYbiology HL practice questions IB BIOLOGY
biology HL practice questions IB BIOLOGY
1301aanya
 
Chemical Tests; flame test, positive and negative ions test Edexcel Internati...
Chemical Tests; flame test, positive and negative ions test Edexcel Internati...Chemical Tests; flame test, positive and negative ions test Edexcel Internati...
Chemical Tests; flame test, positive and negative ions test Edexcel Internati...
ssuser79fe74
 
Introduction,importance and scope of horticulture.pptx
Introduction,importance and scope of horticulture.pptxIntroduction,importance and scope of horticulture.pptx
Introduction,importance and scope of horticulture.pptx
Bhagirath Gogikar
 
Asymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 b
Asymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 bAsymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 b
Asymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 b
Sérgio Sacani
 

Recently uploaded (20)

Biogenic Sulfur Gases as Biosignatures on Temperate Sub-Neptune Waterworlds
Biogenic Sulfur Gases as Biosignatures on Temperate Sub-Neptune WaterworldsBiogenic Sulfur Gases as Biosignatures on Temperate Sub-Neptune Waterworlds
Biogenic Sulfur Gases as Biosignatures on Temperate Sub-Neptune Waterworlds
 
Bacterial Identification and Classifications
Bacterial Identification and ClassificationsBacterial Identification and Classifications
Bacterial Identification and Classifications
 
High Profile 🔝 8250077686 📞 Call Girls Service in GTB Nagar🍑
High Profile 🔝 8250077686 📞 Call Girls Service in GTB Nagar🍑High Profile 🔝 8250077686 📞 Call Girls Service in GTB Nagar🍑
High Profile 🔝 8250077686 📞 Call Girls Service in GTB Nagar🍑
 
biology HL practice questions IB BIOLOGY
biology HL practice questions IB BIOLOGYbiology HL practice questions IB BIOLOGY
biology HL practice questions IB BIOLOGY
 
Proteomics: types, protein profiling steps etc.
Proteomics: types, protein profiling steps etc.Proteomics: types, protein profiling steps etc.
Proteomics: types, protein profiling steps etc.
 
Locating and isolating a gene, FISH, GISH, Chromosome walking and jumping, te...
Locating and isolating a gene, FISH, GISH, Chromosome walking and jumping, te...Locating and isolating a gene, FISH, GISH, Chromosome walking and jumping, te...
Locating and isolating a gene, FISH, GISH, Chromosome walking and jumping, te...
 
Factory Acceptance Test( FAT).pptx .
Factory Acceptance Test( FAT).pptx       .Factory Acceptance Test( FAT).pptx       .
Factory Acceptance Test( FAT).pptx .
 
Site Acceptance Test .
Site Acceptance Test                    .Site Acceptance Test                    .
Site Acceptance Test .
 
Kochi ❤CALL GIRL 84099*07087 ❤CALL GIRLS IN Kochi ESCORT SERVICE❤CALL GIRL
Kochi ❤CALL GIRL 84099*07087 ❤CALL GIRLS IN Kochi ESCORT SERVICE❤CALL GIRLKochi ❤CALL GIRL 84099*07087 ❤CALL GIRLS IN Kochi ESCORT SERVICE❤CALL GIRL
Kochi ❤CALL GIRL 84099*07087 ❤CALL GIRLS IN Kochi ESCORT SERVICE❤CALL GIRL
 
Call Girls Alandi Call Me 7737669865 Budget Friendly No Advance Booking
Call Girls Alandi Call Me 7737669865 Budget Friendly No Advance BookingCall Girls Alandi Call Me 7737669865 Budget Friendly No Advance Booking
Call Girls Alandi Call Me 7737669865 Budget Friendly No Advance Booking
 
Chemical Tests; flame test, positive and negative ions test Edexcel Internati...
Chemical Tests; flame test, positive and negative ions test Edexcel Internati...Chemical Tests; flame test, positive and negative ions test Edexcel Internati...
Chemical Tests; flame test, positive and negative ions test Edexcel Internati...
 
High Class Escorts in Hyderabad ₹7.5k Pick Up & Drop With Cash Payment 969456...
High Class Escorts in Hyderabad ₹7.5k Pick Up & Drop With Cash Payment 969456...High Class Escorts in Hyderabad ₹7.5k Pick Up & Drop With Cash Payment 969456...
High Class Escorts in Hyderabad ₹7.5k Pick Up & Drop With Cash Payment 969456...
 
Dopamine neurotransmitter determination using graphite sheet- graphene nano-s...
Dopamine neurotransmitter determination using graphite sheet- graphene nano-s...Dopamine neurotransmitter determination using graphite sheet- graphene nano-s...
Dopamine neurotransmitter determination using graphite sheet- graphene nano-s...
 
FAIRSpectra - Enabling the FAIRification of Spectroscopy and Spectrometry
FAIRSpectra - Enabling the FAIRification of Spectroscopy and SpectrometryFAIRSpectra - Enabling the FAIRification of Spectroscopy and Spectrometry
FAIRSpectra - Enabling the FAIRification of Spectroscopy and Spectrometry
 
GBSN - Microbiology (Unit 2)
GBSN - Microbiology (Unit 2)GBSN - Microbiology (Unit 2)
GBSN - Microbiology (Unit 2)
 
Introduction,importance and scope of horticulture.pptx
Introduction,importance and scope of horticulture.pptxIntroduction,importance and scope of horticulture.pptx
Introduction,importance and scope of horticulture.pptx
 
IDENTIFICATION OF THE LIVING- forensic medicine
IDENTIFICATION OF THE LIVING- forensic medicineIDENTIFICATION OF THE LIVING- forensic medicine
IDENTIFICATION OF THE LIVING- forensic medicine
 
Asymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 b
Asymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 bAsymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 b
Asymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 b
 
Unit5-Cloud.pptx for lpu course cse121 o
Unit5-Cloud.pptx for lpu course cse121 oUnit5-Cloud.pptx for lpu course cse121 o
Unit5-Cloud.pptx for lpu course cse121 o
 
GBSN - Microbiology (Unit 1)
GBSN - Microbiology (Unit 1)GBSN - Microbiology (Unit 1)
GBSN - Microbiology (Unit 1)
 

Locke test chars

  • 1. INTRO TO TEST CHARACTERISTICS BRIAN LOCKE, MD PGY2 INTERNAL MEDICINE UNIVERSITY OF UTAH UPDATED APR 12 2018
  • 2. OBJECTIVES Be able to: Define sensitivity and specificity Construct a contingency table for a given test and condition What factors influence positive predictive value and negative predictive values?
  • 3. PREVALENCE AND INCIDENCE Measures of how common a disease is: Prevalence = cases per population at risk Incidence = number of new cases per population at risk
  • 4. SENSITIVITY Among patients who have the disease, how often will the test be positive High Sensitivity = almost never misses someone with disease Low sensitivity = can often be negative in someone with disease
  • 5. SPECIFICITY Among patients who do not have the disease, how often will the test be negative? High specificity = test is almost always negative if the person does not have disease Low specificity = test can often be positive in someone who does not have the disease
  • 6. EXAMPLE 1: D-dimer over 500 for pulmonary embolism • Sensitivity = 99.5% • Specificity = 41% • Prevalence in tested outpatients = 29% • Am J Respir Crit Care Med. 1997 Aug;156(2 Pt 1):492-6 How should we interpret a positive or negative result?.
  • 7. CONTINGENCY TABLE Possibilities of disease states and test results Has Disease (D+) Does Not Have Disease (D-) Test positive (T+) Test negative (T-)
  • 8. CONTINGENCY TABLE Possibilities of disease states and test results Has Disease (D+) Does Not Have Disease (D-) Test positive (T+) True Positive False Positive Test negative (T-) False Negative True Negative
  • 9. PREVALENCE AND INCIDENCE Prevalence = cases per population at risk Incidence = number of new cases per population at risk • How does high vs low prevalence affect the contingency table? Has Disease (D+) Does Not Have Disease (D-) Test positive (T+) True Positive False Positive Test negative (T-) False Negative True Negative
  • 10. PREVALENCE AND INCIDENCE Prevalence = cases per population at risk Incidence = number of new cases per population at risk • How does high vs low prevalence affect the contingency table? Amount in each column Has Disease (D+) Does Not Have Disease (D-) Test positive (T+) True Positive False Positive Test negative (T-) False Negative True Negative
  • 11. EXAMPLE 1: Has Disease (D+) = 2900 Does Not Have Disease (D-) = 7100 Test positive (T+) True Positive False Positive Test negative (T-) False Negative True Negative D-dimer over 500 for pulmonary embolism • Sensitivity = 99.5% • Specificity = 41% • Prevalence in tested outpatients = 29% • Am J Respir Crit Care Med. 1997 Aug;156(2 Pt 1):492-6 Let’s consider 10,000 hypothetical patients evaluated for PE:
  • 12. SENSITIVITY Among patients who have the disease, how often will the test be positive Has Disease (D+) Does Not Have Disease (D-) Test positive (T+) True Positive False Positive Test negative (T-) False Negative True Negative
  • 13. SENSITIVITY Among patients who have the disease, how often will the test be positive = True Positive / (True Positive + False Negatives) Has Disease (D+) Does Not Have Disease (D-) Test positive (T+) True Positive False Positive Test negative (T-) False Negative True Negative
  • 14. SPECIFICITY Among patients who do not have the disease, how often will the test be negative Has Disease (D+) Does Not Have Disease (D-) Test positive (T+) True Positive False Positive Test negative (T-) False Negative True Negative
  • 15. SPECIFICITY Among patients who do not have the disease, how often will the test be negative =True Negative / (False Positive + True Negative) Has Disease (D+) Does Not Have Disease (D-) Test positive (T+) True Positive False Positive Test negative (T-) False Negative True Negative
  • 16. EXAMPLE 1: D-dimer over 500 for pulmonary embolism • Sensitivity = 99.5% • Specificity = 41% • Prevalence in tested outpatients = 29% • Am J Respir Crit Care Med. 1997 Aug;156(2 Pt 1):492-6 Specificity = True Negative / All Negative Sensitivity = True Positive / All Positive Has Disease (D+) = 2900 Does Not Have Disease (D-) = 7100 Test positive (T+) True Positive False Positive Test negative (T-) False Negative True Negative
  • 17. EXAMPLE 1: D-dimer over 500 for pulmonary embolism • Sensitivity = 99.5% • Specificity = 41% • Prevalence in tested outpatients = 29% • Am J Respir Crit Care Med. 1997 Aug;156(2 Pt 1):492-6 41% = True Negative / 7100 99.5% = True Positive / 2900 Has Disease (D+) = 2900 Does Not Have Disease (D-) = 7100 Test positive (T+) True Positive False Positive Test negative (T-) False Negative True Negative
  • 18. EXAMPLE 1: D-dimer over 500 for pulmonary embolism • Sensitivity = 99.5% • Specificity = 41% • Prevalence in tested outpatients = 29% • Am J Respir Crit Care Med. 1997 Aug;156(2 Pt 1):492-6 True Negative = 7100 * .41 = 2911 True Positive = 2900 * .995 = 2885 Has Disease (D+) = 2900 Does Not Have Disease (D-) = 7100 Test positive (T+) True Positive False Positive Test negative (T-) False Negative True Negative
  • 19. EXAMPLE 1: Has Disease (D+) = 2900 Does Not Have Disease (D-) = 7100 Test positive (T+) 2885 4189 (=7100-2911) Test negative (T-) 5 (=2900–2885) 2911 D-dimer over 500 for pulmonary embolism • Sensitivity = 99.5% • Specificity = 41% • Prevalence in tested outpatients = 29% • Am J Respir Crit Care Med. 1997 Aug;156(2 Pt 1):492-6 True Negative = 7100 * .41 = 2911 True Positive = 2900 * .995 = 2885
  • 20. POSITIVE PREDICTIVE VALUE Among patients who test positive for the disease, how often they have the disease Why do we care? Because we don’t know whether the patient has the disease or not!
  • 21. POSITIVE PREDICTIVE VALUE Among patients who test positive for the disease, how often they have the disease *requires that we know the prevalence Unlike the sensitivity and specificity, it will vary with prevalence. Sensitivity and specificity are characteristics of the test.
  • 22. POSITIVE PREDICTIVE VALUE Among patients who test positive for the disease, how often they have the disease = True Positives / (True Positive + False Positives) Has Disease (D+) Does Not Have Disease (D-) Test positive (T+) True Positive False Positive Test negative (T-) False Negative True Negative
  • 23. NEGATIVE PREDICTIVE VALUE Among patients who test negative for the disease, how often they not have the disease = True Negative / (False Negative + True Negative) Has Disease (D+) Does Not Have Disease (D-) Test positive (T+) True Positive False Positive Test negative (T-) False Negative True Negative
  • 24. EXAMPLE 1: Has Disease (D+) = 2900 Does Not Have Disease (D-) = 7100 Test positive (T+) 2885 4189 Test negative (T-) 5 2911 D-dimer over 500 for pulmonary embolism • Sensitivity = 99.5% • Specificity = 41% • Prevalence in tested outpatients = 29% • Am J Respir Crit Care Med. 1997 Aug;156(2 Pt 1):492-6 • PPV = 2885 / (2885 + 4189) = 41% • NPV = 2911 / ( 2911 + 5) = 99.8%
  • 25. EXAMPLE 1B: D-dimer over 500 for pulmonary embolism • Sensitivity = 99.5% • Specificity = 41% • Prevalence in tested outpatients = 75% • Hypothetical population with very convincing signs and symptoms
  • 26. EXAMPLE 1B: Has Disease (D+) = 7500 Does Not Have Disease (D-) = 2500 Test positive (T+) True Positive False Positive Test negative (T-) False Negative True Negative D-dimer over 500 for pulmonary embolism • Sensitivity = 99.5% • Specificity = 41% • Prevalence in tested outpatients = 75% • Hypothetical population with very convincing signs and symptoms
  • 27. EXAMPLE 1B: Has Disease (D+) = 7500 Does Not Have Disease (D-) = 2500 Test positive (T+) 7463 1475 Test negative (T-) 37 1025 D-dimer over 500 for pulmonary embolism • Sensitivity = 99.5% • Specificity = 41% • Prevalence in tested outpatients = 75% • Hypothetical population with very convincing signs and symptoms
  • 28. EXAMPLE 1B: D-dimer over 500 for pulmonary embolism • Sensitivity = 99.5% • Specificity = 41% • Prevalence in tested outpatients = 75% • Hypothetical population with very convincing signs and symptoms • PPV = 7463 / (7463 + 1475) = 83% • NPV = 1025 / ( 1025 + 37) = 96.5% Has Disease (D+) = 7500 Does Not Have Disease (D-) = 2500 Test positive (T+) 7463 1475 Test negative (T-) 37 1025
  • 29. EXAMPLE 2: Testing for Rare disease • E.g. 24h Urine Metanephrines for Pheochromocytoma (warning: made up numbers) = prevalence of 1% (among tested patients) • Sensitivity = 99% • Specificity = 99% • PPV of a positive result?
  • 30. EXAMPLE 2: Testing for Rare disease • E.g. 24h Urine Metanephrines for Pheochromocytoma (warning: made up numbers) = prevalence of 1% (among tested patients) • Sensitivity = 99% • Specificity = 99% Has Disease (D+) =100 Does Not Have Disease (D-) = 9900 Test positive (T+) 99 99 Test negative (T-) 1 9801
  • 31. EXAMPLE 2: Testing for Rare disease • Test positive => 99 True positive, 99 False positive! • PPV 50% Even good tests are not reliable in low prevalence conditions Has Disease (D+) =100 Does Not Have Disease (D-) = 9900 Test positive (T+) 99 99 Test negative (T-) 1 9801
  • 32. EXAMPLE 3 Lung Ca Screening w/ Low dose CT: (Br J Cancer. 2008 May 20;98(10):1602-7) • Sensitivity 88.9, Specificity 92.6 • Prevalence: age-adjusted incidence rate of lung cancer is 62 per 100,000 men and women per year in the United States (Clin Chest Med. 2011 Dec; 32(4): 10.1016/j.ccm.2011.09.001.)
  • 33. OBJECTIVES Be able to: Define sensitivity and specificity Construct a contingency table for testing for a given condition What factors influence positive predictive value and negative predictive values?
  • 34. OBJECTIVES Be able to: Define sensitivity and specificity Sensitivity = If a patient has the disease, how often will the test be positive? Specificity = if the patient does not have the disease, how often will the test be negative? Construct a contingency table for testing for a given condition Calculate # w/ and w/o dz, use sensitivity on pts w/ and specificity on pts w/o What factors influence positive predictive value and negative predictive values? PPV increases w/ higher specificity+sensitivity and prevalence NPV increases w/ high specificity+sensitivity and lower prevalence
  • 35. NEXT STEPS How can we use these characteristics? • Likelihood ratio • Bayes Theorem • Expected Value Theorem • Questions? Brian.locke@hsc.utah.edu

Editor's Notes

  1. Need numerous lines of evidence